Naba Alsaha Medical Services Company

9546.SRSAUHealthcare● Active

$22.85

+$0.45(+2.01%)

Market Cap$479850000

P/E Ratio—

52W High$34.65

52W Low$20.37

Avg Volume5K

Open$22.99

Beta-0.44

Overview

Naba Alsaha Medical Services Company (9546.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

9546.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

9546.SR · FCF · TTM · margin & CAGR

Free cash flow was −$51.2M for FY2025 (fiscal year ending 2025-12-31), down 1758.7% year-over-year The FCF margin was -25.4%.

FY2025 Free Cash Flow−$51.2M▼ -1758.7% YoY

Trailing 12M (TTM)−$53.9Mtrailing 4 quarters sum

FCF Margin-25.4%−$51.2M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

9546.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$26.8M(78M)−$51.2M▼ 1758.7%-25.4%

FY2024$35.6M(38M)−$2.8M▲ +77.3%-1.4%

FY2023$29.4M(42M)−$12.1M▼ 149.7%-6.7%

FY2022$35.5M(11M)$24.4M▲ +20.0%18.9%

FY2021$30.7M(10M)$20.4M▲ +160.6%17.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

9546.SR · P/FCF · FCF yield · FCF per share

Naba Alsaha Medical Services Company (9546.SR) reported negative free cash flow of −$0.05B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

9546.SR · cash flow statement · operating / investing / financing

For FY2025, Naba Alsaha Medical Services Company generated $26.8M in operating cash flow and spent 78M in capital expenditures, yielding −$51.2M in free cash flow.

Operating Activities

+$26.8M

Cash from core business operations

2025-12-31

Investing Activities

−$81.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$30.4M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($26.8M) − |CapEx| (78M) = FCF (−$51.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

9546.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Naba Alsaha Medical Services CompanyYOU

9546.SR

−$51.2M-1758.7%-25.4%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Naba Alsaha Medical Services Company (9546.SR) reported free cash flow of −$51.2M for FY2025 (fiscal year ending 2025-12-31), down 1758.7% year-over-year. The FCF margin was -25.4%.

Based on available data, Naba Alsaha Medical Services Company has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $24.4M in FY2022.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

9546.SR free cash flow · 8 questions

Naba Alsaha Medical Services Company free cash flow was −$51.2M for FY2025, down 1758.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$53.9M.

9546.SR free cash flow9546.SR FCF9546.SR FCF 20259546.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Naba Alsaha Medical Services Company · Naba Alsaha Medical Services Company SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026